Toledo becomes bowl eligible for the 14th consecutive season after win over Ball State
Published Thu, 04 Jul 2024 18:23:11 GMT
Annapolis High School teacher named Maryland Teacher of the Year
Published Thu, 04 Jul 2024 18:23:11 GMT
Italy puts scandal-ridden week behind it to beat Malta 4-0 in Euro 2024 qualifying
Published Thu, 04 Jul 2024 18:23:11 GMT
Cravens unleashes fourth quarter air assault to lead Morehead State past Valparaiso
Published Thu, 04 Jul 2024 18:23:11 GMT
New Zealand withstands Ireland comebacks to win Rugby World Cup quarterfinal classic
Published Thu, 04 Jul 2024 18:23:11 GMT
Iowa tight end Erick All, Wisconsin quarterback Tanner Mordecai leave with injuries in first half
Published Thu, 04 Jul 2024 18:23:11 GMT
Brosmer’s 3 touchdown passes lead New Hampshire to 38-31 win over Albany
Published Thu, 04 Jul 2024 18:23:11 GMT
Man killed after gunfire erupts in Fort Lauderdale neighborhood overnight
Published Thu, 04 Jul 2024 18:23:11 GMT
Mertz’s 3 TDs, career day rallies Gators to 41-39 victory over South Carolina
Published Thu, 04 Jul 2024 18:23:11 GMT
More Than Pink Walk, annual breast cancer research fundraiser, held at Amelia Earhart Park
Published Thu, 04 Jul 2024 18:23:11 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says